Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Resignation of Director

On December 18, 2012, Jules A. Müsing resigned from the Board of Directors (the “Board”) of iBio, Inc. (the “Company”).

(d) Appointment of New Director

On December 18, 2012, the Board voted to appoint Seymour Flug to serve on the Board, filling the vacancy created by Mr. Müsing’s departure. Mr. Flug will be one of the Board’s Class III directors, whose members’ terms expire at the Company’s annual meeting to be held in late 2014.

There is no arrangement or understanding between Mr. Flug and any other person, pursuant to which Mr. Flug is to be appointed as a director. Mr. Flug is not a party to any transactions that would require disclosure under Item 404(a) of Regulation S-K.

Mr. Flug was appointed to serve on the Audit Committee of the Board.

In connection with his appointment, Mr. Flug was granted a stock option to purchase 60,000 shares of the Company’s common stock under the Company’s stock incentive plan, which shall vest in three equal annual installments beginning on the first day of Mr. Flug’s service, at an exercise price set at the last trading price on the date of appointment.

On December 21, 2012, the Company issued a press release announcing the appointment of Mr. Flug as well as the addition of Andrea Corcoran, the Company’s new Senior Vice President, Finance and Strategy. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Company’s 2012 Annual Meeting of Stockholders, Proposals 1 and 2 were each approved by the Company’s stockholders. The proposals are described in detail in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on November 16, 2012. The final voting results of the 2012 Annual Meeting are set forth below.

Proposal 1 - Election of Directors - The Company’s stockholders elected Robert B. Kay, General James T. Hill and Arthur Y. Elliott, Ph.D. to serve as Class I directors of the Company for a three-year term expiring in 2015. The voting results for each of these individuals were as follows:

Proposal 2 - Ratification of the Company’s Independent Registered Public Accounting Firm - The Company’s stockholders ratified the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2013. The voting results were 41,345,742 shares “FOR,” 195,670 shares “AGAINST,” and 74,555 abstentions.